Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023

Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as is...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2024-09, Vol.30 (9), p.1903-1906
Main Authors: Caméléna, François, Mérimèche, Manel, Brousseau, Julie, Mainardis, Mary, Verger, Pascale, Le Risbé, Caroll, Brottet, Elise, Thabuis, Alexandra, Bébéar, Cécile, Molina, Jean-Michel, Lot, Florence, Chazelle, Emilie, Berçot, Béatrice
Format: Article
Language:English
Subjects:
Antimicrobial agents
antimicrobial resistance
bacteria
Bacterial infections
Care and treatment
Case studies
Diagnosis
Disease prevention
Dispatch
Drug resistance
Drug-resistant
Emergence of Extensively Drug-Resistant
France, 2023
Genomes
Gonorrhea
Infections
Mutation
Neisseria gonorrhoeae
Patients
penA-60.001
Penicillin
Public health
Sexually transmitted diseases
STD
Surveillance
Working groups
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as isolates from Cambodia.
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid3009.240557